BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 29603271)

  • 1. Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: Long-term oncologic outcomes.
    Lubbers M; van Det MJ; Kreuger MJ; Hoekstra R; Hendriksen EM; Vermeer M; Kouwenhoven EA
    J Surg Oncol; 2018 Mar; 117(4):651-658. PubMed ID: 29603271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.
    Woodard GA; Crockard JC; Clary-Macy C; Zoon-Besselink CT; Jones K; Korn WM; Ko AH; Gottschalk AR; Rogers SJ; Jablons DM
    J Surg Oncol; 2016 Dec; 114(7):838-847. PubMed ID: 27569043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short-term outcomes of robot-assisted minimally invasive esophagectomy for esophageal cancer].
    Tan Z; Zhang X; Wang X; Fu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):995-998. PubMed ID: 27680066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN
    JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70.
    Blom RL; van Heijl M; Klinkenbijl JH; Bergman JJ; Wilmink JW; Richel DJ; Hulshof MC; Reitsma JB; Busch OR; van Berge Henegouwen MI
    Dis Esophagus; 2013 Jul; 26(5):510-6. PubMed ID: 22925313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.
    Warner S; Chang YH; Paripati H; Ross H; Ashman J; Harold K; Day R; Stucky CC; Rule W; Jaroszewski D
    Ann Thorac Surg; 2014 Feb; 97(2):439-45. PubMed ID: 24266955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
    Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
    Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified Neoadjuvant Chemoradiotherapy for Patients with Potentially Resectable Esophageal Cancer: A Retrospective Cohort Study.
    Boers J; Joldersma A; van Dalsen AD; Wiegman EM; Schenk BE; de Graaf JC; Pierik EGJM; Timmer PR; de Groot JWB
    Ann Surg Oncol; 2020 May; 27(5):1520-1528. PubMed ID: 31828691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers.
    Straatman J; van der Wielen N; Nieuwenhuijzen GA; Rosman C; Roig J; Scheepers JJ; Cuesta MA; Luyer MD; van Berge Henegouwen MI; van Workum F; Gisbertz SS; van der Peet DL
    Surg Endosc; 2017 Jan; 31(1):119-126. PubMed ID: 27129563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.
    Koëter M; van der Sangen MJ; Hurkmans CW; Luyer MD; Rutten HJ; Nieuwenhuijzen GA
    Radiat Oncol; 2015 Mar; 10():59. PubMed ID: 25884226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe Introduction of Minimally Invasive Esophagectomy at a Medium Volume Center.
    Linder G; Jestin C; Sundbom M; Hedberg J
    Scand J Surg; 2020 Jun; 109(2):121-126. PubMed ID: 30739555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.
    Nabavizadeh N; Shukla R; Elliott DA; Mitin T; Vaccaro GM; Dolan JP; Maggiore RJ; Schipper PH; Hunter JG; Thomas CR; Holland JM
    Dis Esophagus; 2016 Aug; 29(6):614-20. PubMed ID: 26043837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term efficacy and safety of the synchronous neoadjuvant chemoradiotherapy with paclitaxel plus carboplatin in stage III adenocarcinoma of esophagogastric junction].
    Ji Y; Peng T; Wang G; Zhang Y; Cao M; Gao Q; Li S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1019-1024. PubMed ID: 30269322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive esophagectomy may contribute to long-term respiratory function after esophagectomy for esophageal cancer.
    Kosumi K; Yoshida N; Okadome K; Eto T; Kuroda D; Ohuchi M; Kiyozumi Y; Nakamura K; Izumi D; Tokunaga R; Harada K; Mima K; Sawayama H; Ishimoto T; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Baba H
    Dis Esophagus; 2018 Jun; 31(6):. PubMed ID: 29444214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally Invasive Salvage Operations for Esophageal Cancer after Definitive Chemoradiotherapy.
    Nakajima M; Kato H; Muroi H; Kikuchi M; Takahashi M; Yamaguchi S; Sasaki K; Ishikawa H; Sakurai H; Kuwano H
    Digestion; 2018; 97(1):64-69. PubMed ID: 29393232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally Invasive Esophagectomy: A New Era of Surgical Resection.
    Treitl D; Hurtado M; Ben-David K
    J Laparoendosc Adv Surg Tech A; 2016 Apr; 26(4):276-80. PubMed ID: 27046331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary experience with minimally invasive Ivor Lewis esophagectomy.
    Tapias LF; Morse CR
    Dis Esophagus; 2012 Jul; 25(5):449-55. PubMed ID: 21967644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.